Daily Reporter

Are we reaching a turning point in metastatic prostate cancer?

At yesterday’s Presidential Symposium, a Late-Breaking Abstract presentation of the PROfound study reported a clinically meaningful benefit in radiological progression-free survival (PFS) with olaparib in men with BRCA1, BRCA2 or ATM mutations in metastatic castration-resistant…

Read More



‘A train to ESMO’ for the climate

Achieving a sustainable cancer care in a sustainable world. This is the idea that moved Dr Joakim Crona from the University Hospital Uppsala Akademiska Sjukhuset, Sweden, to run an initiative – ‘A train to ESMO’…

Watch Here

Understanding the genetics of cancer in adolescents

As genetic analysis becomes cheaper and more widely available, oncologists are getting close to an era where tumour—somatic—and germline testing will form a greater component of the management of adolescents and young adults (AYA) with…

Read More

Closing the clinician–patient gap with patient-reported outcomes

Cancer has dozens of common symptoms and adverse events—such as pain, fatigue, nausea, vomiting, neuropathy, mouth sores, appetite problems, taste problems, anxiety and sleeplessness—which may be interpreted differently by patients and healthcare professionals. Patient-reported outcomes…

Read More